Baxter International Inc. (NYSE:BAX) faced a massive sell-off, dropping to a new 52-week low as investors reacted negatively to its lower earnings growth forecast. Shares plummeted by 22.42 percent to $21.76 apiece, with intra-day trading hitting $21.47. The company reported a swing to a net income of $91 million in the second quarter, up from a $314 million loss the previous year, with net sales increasing by 4 percent to $2.8 billion. Baxter International Inc. (NYSE:BAX) adjusted its EPS outlook to $2.42-$2.52, below analyst expectations of $2.52 per share, citing demand weakness for IV fluids.

Read more at Yahoo Finance: Baxter International (BAX) Falls to New Low on Disappointing Growth Forecast